Leaflet CO-DERGOCRIN 0.1% oral solution in drops

Indicated for: cognitive disorders; cerebral circulatory disorders

Route of administration: oral

Substance: codergocrine (alkaloid derivative)

ATC: C04AE01 (Cardiovascular system | Peripheral vasodilators | Ergot alkaloids)

Codergocrine is an ergot derivative used for the treatment of cerebral and peripheral circulatory disorders. It works by improving blood flow and reducing vascular resistance, helping to alleviate associated symptoms.

The medication is administered orally or by injection, as directed by a doctor. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.

Patients should be aware of potential side effects, such as nausea, dizziness, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, dizziness, and headaches. In rare cases, severe reactions such as vasospasm or allergic reactions may occur. Patients should be informed of these risks before use.

General data about CO-DERGOCRIN 0.1%

  • Substance: codergocrine
  • Date of latest medicines list: 01-07-2013
  • Product code: W42639001
  • Concentration: 0.1%
  • Pharmaceutical form: oral solution in drops
  • Quantity: 1
  • Product type: Generic medicine
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Pharmaceutical forms available for codergocrine

Concentrations available for codergocrine

  • 0.1%
  • 0.3mg/ml
  • 1mg/ml